Enterprise Value
39.22M
Cash
7.874M
Avg Qtr Burn
-5.287M
Short % of Float
2.04%
Insider Ownership
21.38%
Institutional Own.
36.03%
Qtr Updated
03/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
DCCR (Diazoxide Choline Controlled-Release) (K ATP agonist) Details Prader-Willi syndrome, Genetic disorder | Phase 3 Data readout |